GRACEcast Bladder Cancer Video

By cancerGRACE - H. Jack West, MDMedicine Education

GRACEcast Bladder Cancer Video episodes

August 11, 2013 ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of radiation for stage III unresectable NSCLC.
9 min
August 07, 2013 ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (video)
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC with chemo/radiation as introduction to key issues addressed in trials from ASCO 2013.
8 min
August 07, 2013 ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC with chemo/radiation as introduction to key issues addressed in trials from ASCO 2013.
8 min
August 06, 2013 Dr. Bob Doebele: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?
Dr. Bob Doebele from the University of Colorado, offers his insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more multifocal progression after a good initial response to a targeted agent.
3 min
August 06, 2013 Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors
Dr. Phil Bonomi, from Rush University, describes the generations of EGFR inhibitors beginning with Gefitinib (Iressa).
2 min
July 29, 2013 Dr. David Spigel on "Which molecular marker tests do you seek?"
Dr. David Spigel, Sarah Cannon Cancer Center, describes which molecular markers he seeks for NSCLC patients.
1 min
July 22, 2013 HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (video)
Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.
15 min
July 22, 2013 HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (audio)
Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.
15 min
July 22, 2013 HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (video)
Dr. Jared Weiss from the University of North Carolina, Chapel Hill introduces us to the human papilloma virus and its role as a cause and relevant prognostic factor for head and neck cancer (HNSCC).
8 min
July 22, 2013 HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (audio)
GRACE, cancerGRACE, GRACEcast, Jared Weiss, Unveristy of North Carolina-Chapel Hill, UNC-Chapel Hill, induction therapy, neoadjuvant therapy, head and neck cancer, HNSCC, carbplatin, paclitaxel, cetuximab, Taxol, Erbitux, weekly
8 min

About GRACEcast Bladder Cancer Video

From the publisher's feed

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to…